Hennigsdorf, Germany Clinical Trials

A listing of Hennigsdorf, Germany clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 17 clinical trials
Hypofractionation With Simultaneous Integrated Boost vs. Standard Fractionation in Early Breast Cancer

Hypofractionation with simultaneous integrated boost has been investigated in a few trials and appears to be safe and feasible. Investigators initiated this multicenter two-armed phase III prospective trial to analyse the non-inferiority of hypofractionation with simultaneous integrated boost in patients with early breast cancer in comparison to standard fractionation.

her-2
breast conserving surgery
mastectomy
estrogen
bisphosphonate
DRK Kliniken Berlin: Zentrum f r Strahlentherapie MVZ pro patiente Westend
 (8.3 away) Contact site
  • 7 views
  • 21 Jan, 2021
  • +46 other locations
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab Followed by Maintenance Durvalumab Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients.

This is a Phase III randomised, double-blind, multi-centre study to evaluate the efficacy and safety of durvalumab in combination with standard of care platinum based chemotherapy and bevacizumab followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian cancer.

Research Site
 (5.2 away) Contact site
  • 84 views
  • 13 Jun, 2021
  • +286 other locations
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines

The purpose of this study is to assess the safety and efficacy profile of increasing doses of IPN10200 in comparison to placebo, with the aim to discover the doses(s) that offer the best efficacy/safety profile when used for the treatment of moderate to severe Upper Facial Lines. This study will …

CRS Clinical Research Services Berlin GmbH
 (8.8 away) Contact site
  • 0 views
  • 28 Apr, 2021
  • 1 location
Pazopanib vs. Pazopanib Plus Gemcitabine

This study is a prospective, randomized, open-label, multicenter phase II trial in order to determine progression-free survival of patients with refractory or relapsed metastatic uterine leiomyosarcomas or other metastatic uterine tumours.

Charit Campus Virchow-Klinikum Universit tsmedizin Berlin
 (8.8 away) Contact site
  • 2 views
  • 28 Jan, 2021
  • +15 other locations
Endometrial Cancer Lymphadenectomy Trial

The primary aim of this trial is to ascertain whether or not systematic pelvic and para-aortic lymphadenectomy (LNE) does have a significant impact on overall survival (OS) in patients with endometrial cancer (EC) FIGO Stages I or II and high risk of recurrence. Secondary aims will be to evaluate the …

Vivantes Humboldt-Klinikum, Klinik f r Gyn kologie und Geburtsmedizin
 (5.2 away) Contact site
  • 30 views
  • 10 Jun, 2021
  • +82 other locations
Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO]

This is a prospective, multicenter, double-blind, placebo-controlled, randomized Phase 3 study. The purpose of the study is to obtain evidence of efficacy for maintenance selinexor in participants with advanced or recurrent endometrial cancer. Participants with primary stage IV or recurrent disease who are in partial or complete response after having …

uterine carcinosarcoma
recurrent endometrial cancer
platelet count
metastasis
carcinosarcoma
Charite Berlin Universitatsmedizin
 (8.8 away) Contact site
  • 47 views
  • 04 Jun, 2021
  • +102 other locations
RHEIA (Randomized researcH in womEn All Comers With Aortic Stenosis)

Purpose of this prospective, randomized, controlled, multi-center study is to evaluate the safety and efficacy of Transcatheter Aortic Valve Implantation (TAVI) as compared to surgical aortic valve replacement (SAVR) in female patients with severe symptomatic aortic stenosis. Patients will be randomized 1:1 to receive either TAVI or SAVR aortic valve …

transcatheter aortic valve implantation
aortic valve stenosis
exercise test
symptomatic aortic stenosis
aortic valve replacement
Deutsches Herzzentrum Berlin
 (8.8 away) Contact site
  • 94 views
  • 26 Jan, 2021
  • +35 other locations
Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)

The purpose of this study is to evaluate the efficacy and safety of pembrolizumab plus concurrent chemoradiotherapy compared to placebo plus concurrent chemoradiotherapy in participants with locally advanced cervical cancer. The primary hypotheses are that pembrolizumab plus concurrent chemoradiotherapy is superior to placebo plus concurrent chemoradiotherapy with respect to progression-free …

carcinoma
x-rays
squamous cell carcinoma
adenosquamous carcinoma
adenocarcinoma
Charite Universitaetsmedizin Berlin ( Site 0442)
 (8.8 away) Contact site
  • 85 views
  • 13 Jun, 2021
  • +154 other locations
Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

The purpose of this study is to assess the efficacy and safety of treatment with carboplatin/paclitaxel* PLUS pembrolizumab (MK-3475) and maintenance olaparib (MK-7339) in women with epithelial ovarian cancer (EOC), fallopian tube cancer, or primary peritoneal cancer. The primary study hypotheses are that the combination of pembrolizumab plus carboplatin/paclitaxel* followed …

debulking surgery
cancer chemotherapy
olaparib
interval debulking surgery
solid tumour
Charite Campus Virchow-Klinikum - CVK ( Site 0700)
 (8.8 away) Contact site
  • 732 views
  • 14 Jun, 2021
  • +258 other locations
Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb

The purpose of this study is to assess safety and efficacy of BAY1817080 compared to elagolix and placebo in women with symptomatic endometriosis. Study details include: Study duration: 155 up to 285 days Treatment duration: 84 days Visit frequency: approximately once a month

analgesic
laparotomy
endometriosis
laparoscopy
ibuprofen
Charit - Campus Virchow-Klinikum (CVK)
 (8.8 away) Contact site
  • 0 views
  • 03 Jun, 2021
  • +201 other locations